Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Horizontal Bone Augmentation
and you are
between 18 and 80
years old
The phase for this study is not defined.
Show me locations

The purpose

This clinical investigation is a prospective, multi-centre study to evaluate bone gain after horizontal augmentation using creos xenogain bone graft substitute. Patients included in the study are in need of a GBR procedure prior to implant placement in the premolar and posterior region of the mandible.

Provided treatments

  • Device: creos xenogain
Wondering what is the locations section for?
We will connect you to the doctor responsible for this trial and help you get more information.

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT03028922. The sponsor of the trial is Nobel Biocare and it is looking for 42 volunteers for the current phase.
Official trial title:
A Prospective, Multi-centre Study Evaluating Creos™ Xenogain Bone Graft Substitute in Horizontal Ridge Augmentation in the Premolar and Molar Region of the Mandible